home / stock / pktx / pktx quote
Last: | $0.0141 |
---|---|
Change Percent: | 7.5% |
Open: | $0.0111 |
Close: | $0.0141 |
High: | $0.0141 |
Low: | $0.0111 |
Volume: | 25,000 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0141 | $0.0111 | $0.0141 | $0.0141 | $0.0111 | 25,000 | 07-19-2024 |
$0.012 | $0.01284 | $0.012 | $0.01326 | $0.012 | 98,498 | 07-18-2024 |
$0.0144 | $0.0139 | $0.0144 | $0.0144 | $0.01 | 15,750 | 07-17-2024 |
$0.0094 | $0.0123 | $0.0094 | $0.0123 | $0.0094 | 47,001 | 07-16-2024 |
$0.01126 | $0.0138 | $0.01126 | $0.0138 | $0.0093 | 39,750 | 07-15-2024 |
$0.0138 | $0.0139 | $0.0138 | $0.0139 | $0.01155 | 46,495 | 07-12-2024 |
$0.01165 | $0.01165 | $0.01165 | $0.01165 | $0.01165 | 100 | 07-11-2024 |
$0.0137 | $0.0106 | $0.0137 | $0.0145 | $0.0092 | 446,333 | 07-10-2024 |
$0.012 | $0.0118 | $0.012 | $0.012 | $0.0092 | 219,000 | 07-09-2024 |
$0.0118 | $0.0086 | $0.0118 | $0.0118 | $0.0086 | 35,455 | 07-08-2024 |
$0.011 | $0.01145 | $0.011 | $0.0118 | $0.011 | 270,232 | 07-05-2024 |
$0.0119 | $0.011 | $0.0119 | $0.0119 | $0.0101 | 266,539 | 07-04-2024 |
$0.0119 | $0.011 | $0.0119 | $0.0119 | $0.0101 | 266,539 | 07-03-2024 |
$0.01005 | $0.0109 | $0.01005 | $0.011 | $0.01005 | 107,500 | 07-02-2024 |
$0.008 | $0.0103 | $0.008 | $0.011 | $0.008 | 236,976 | 07-01-2024 |
$0.01 | $0.011 | $0.01 | $0.011 | $0.01 | 3,000 | 06-28-2024 |
$0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 60,800 | 06-27-2024 |
$0.01 | $0.0081 | $0.01 | $0.012 | $0.0081 | 174,249 | 06-25-2024 |
$0.0114 | $0.011 | $0.0114 | $0.0114 | $0.011 | 340,000 | 06-24-2024 |
$0.0107 | $0.01 | $0.0107 | $0.0107 | $0.01 | 10,000 | 06-21-2024 |
News, Short Squeeze, Breakout and More Instantly...
ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated fr...
ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diab...
ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no opti...